-
1
-
-
0024847626
-
Adenovirus E1A protein paradigm viral transactivator
-
Flint J, Shenk T. 1989. Adenovirus E1A protein paradigm viral transactivator. Annu. Rev. Genet. 23:141-161. http://dx.doi.org/10.1146/annurev.ge .23.120189.001041.
-
(1989)
Annu. Rev. Genet.
, vol.23
, pp. 141-161
-
-
Flint, J.1
Shenk, T.2
-
2
-
-
0023914010
-
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
-
Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124-129. http://dx.doi.org/10.1038/334124a0.
-
(1988)
Nature
, vol.334
, pp. 124-129
-
-
Whyte, P.1
Buchkovich, K.J.2
Horowitz, J.M.3
Friend, S.H.4
Raybuck, M.5
Weinberg, R.A.6
Harlow, E.7
-
3
-
-
0025370654
-
Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis
-
Howe JA, Mymryk JS, Egan C, Branton PE, Bayley ST. 1990. Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis. Proc. Natl. Acad. Sci. U. S. A. 87:5883-5887. http: //dx.doi.org/10.1073/pnas.87.15.5883.
-
(1990)
Proc. Natl. Acad. Sci. U. S. A.
, vol.87
, pp. 5883-5887
-
-
Howe, J.A.1
Mymryk, J.S.2
Egan, C.3
Branton, P.E.4
Bayley, S.T.5
-
4
-
-
0036088252
-
Adenovirus-5 E1A: paradox and paradigm
-
Frisch SM, Mymryk JS. 2002. Adenovirus-5 E1A: paradox and paradigm. Nat. Rev. Mol. Cell Biol. 3:441-452. http://dx.doi.org/10.1038/nrm827.
-
(2002)
Nat. Rev. Mol. Cell Biol.
, vol.3
, pp. 441-452
-
-
Frisch, S.M.1
Mymryk, J.S.2
-
5
-
-
0034610723
-
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
-
Fueyo J, Gomez-Manzano C, Alemany R, Lee PS, McDonnell TJ, Mitlianga P, Shi YX, Levin VA, Yung WK, Kyritsis AP. 2000. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene 19:2-12. http://dx.doi.org/10.1038/sj.onc.1203251.
-
(2000)
Oncogene
, vol.19
, pp. 2-12
-
-
Fueyo, J.1
Gomez-Manzano, C.2
Alemany, R.3
Lee, P.S.4
McDonnell, T.J.5
Mitlianga, P.6
Shi, Y.X.7
Levin, V.A.8
Yung, W.K.9
Kyritsis, A.P.10
-
6
-
-
0033782862
-
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
-
Heise C, Hermiston T, Johnson L, Brooks G, Sampson-Johannes A, Williams A, Hawkins L, Kirn D. 2000. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat. Med. 6:1134-1139. http://dx.doi.org/10.1038/80474.
-
(2000)
Nat. Med.
, vol.6
, pp. 1134-1139
-
-
Heise, C.1
Hermiston, T.2
Johnson, L.3
Brooks, G.4
Sampson-Johannes, A.5
Williams, A.6
Hawkins, L.7
Kirn, D.8
-
7
-
-
0033759405
-
Production of first generation adenovirus vectors: a review
-
Danthinne X, Imperiale MJ. 2000. Production of first generation adenovirus vectors: a review. Gene Ther. 7:1707-1714. http://dx.doi.org/10 .1038/sj.gt.3301301.
-
(2000)
Gene Ther.
, vol.7
, pp. 1707-1714
-
-
Danthinne, X.1
Imperiale, M.J.2
-
8
-
-
3142740855
-
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer
-
Bauerschmitz GJ, Kanerva A, Wang M, Herrmann I, Shaw DR, Strong TV, Desmond R, Rein DT, Dall P, Curiel DT, Hemminki A. 2004. Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer. Int. J. Cancer 111:303-309. http://dx.doi.org /10.1002/ijc.20217.
-
(2004)
Int. J. Cancer
, vol.111
, pp. 303-309
-
-
Bauerschmitz, G.J.1
Kanerva, A.2
Wang, M.3
Herrmann, I.4
Shaw, D.R.5
Strong, T.V.6
Desmond, R.7
Rein, D.T.8
Dall, P.9
Curiel, D.T.10
Hemminki, A.11
-
9
-
-
35148891675
-
A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms
-
Delgado-Enciso I, Cervantes-Garcia D, Martinez-Davila IA, Ortiz-Lopez R, Alemany-Bonastre R, Silva-Platas CI, Lugo-Trampe A, Barrera-Saldana HA, Galvan-Salazar HR, Coronel-Tene CG, Sanchez-Santillan CF, Rojas-Martinez A. 2007. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms. J. Gene Med. 9:852-861. http://dx.doi.org/10.1002/jgm.1071.
-
(2007)
J. Gene Med.
, vol.9
, pp. 852-861
-
-
Delgado-Enciso, I.1
Cervantes-Garcia, D.2
Martinez-Davila, I.A.3
Ortiz-Lopez, R.4
Alemany-Bonastre, R.5
Silva-Platas, C.I.6
Lugo-Trampe, A.7
Barrera-Saldana, H.A.8
Galvan-Salazar, H.R.9
Coronel-Tene, C.G.10
Sanchez-Santillan, C.F.11
Rojas-Martinez, A.12
-
10
-
-
33751005823
-
Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging
-
Lamfers ML, Fulci G, Gianni D, Tang Y, Kurozumi K, Kaur B, Moeniralm S, Saeki Y, Carette JE, Weissleder R, Vandertop WP, van Beusechem VW, Dirven CM, Chiocca EA. 2006. Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging. Mol. Ther. 14:779-788. http://dx.doi.org/10.1016/j.ymthe.2006.08.008.
-
(2006)
Mol. Ther.
, vol.14
, pp. 779-788
-
-
Lamfers, M.L.1
Fulci, G.2
Gianni, D.3
Tang, Y.4
Kurozumi, K.5
Kaur, B.6
Moeniralm, S.7
Saeki, Y.8
Carette, J.E.9
Weissleder, R.10
Vandertop, W.P.11
van Beusechem, V.W.12
Dirven, C.M.13
Chiocca, E.A.14
-
11
-
-
37549009936
-
Differential effects of combined Ad5-delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma
-
Lamfers ML, Idema S, Bosscher L, Heukelom S, Moeniralm S, van der Meulen-Muileman IH, Overmeer RM, van der Valk P, van Beusechem VW, Gerritsen WR, Vandertop WP, Dirven CM. 2007. Differential effects of combined Ad5-delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma. Clin. Cancer Res. 13:7451-7458. http://dx.doi.org/10.1158/1078-0432.CCR-07-1265.
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 7451-7458
-
-
Lamfers, M.L.1
Idema, S.2
Bosscher, L.3
Heukelom, S.4
Moeniralm, S.5
van der Meulen-Muileman, I.H.6
Overmeer, R.M.7
van der Valk, P.8
van Beusechem, V.W.9
Gerritsen, W.R.10
Vandertop, W.P.11
Dirven, C.M.12
-
12
-
-
38449122062
-
Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck
-
Curiel DT, Siegal GP, Rosenthal EL, Rivera AA, Ji S, Wang M, Lu B, Makhija SK, Mathis JM, Zhu ZB. 2007. Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck. Int. J. Oncol. 31:1213-1222. http://www.spandidos -publications.com/ijo/31/5/1213.
-
(2007)
Int. J. Oncol.
, vol.31
, pp. 1213-1222
-
-
Curiel, D.T.1
Siegal, G.P.2
Rosenthal, E.L.3
Rivera, A.A.4
Ji, S.5
Wang, M.6
Lu, B.7
Makhija, S.K.8
Mathis, J.M.9
Zhu, Z.B.10
-
13
-
-
0036828125
-
Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints
-
Reid T, Galanis E, Abbruzzese J, Sze D, Wein LM, Andrews J, Randlev B, Heise C, Uprichard M, Hatfield M, Rome L, Rubin J, Kirn D. 2002. Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints. Cancer Res. 62:6070-6079. http://cancerres.aacrjournals.org/content/62/21/6070.full.pdf.
-
(2002)
Cancer Res.
, vol.62
, pp. 6070-6079
-
-
Reid, T.1
Galanis, E.2
Abbruzzese, J.3
Sze, D.4
Wein, L.M.5
Andrews, J.6
Randlev, B.7
Heise, C.8
Uprichard, M.9
Hatfield, M.10
Rome, L.11
Rubin, J.12
Kirn, D.13
-
14
-
-
0242290921
-
E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models
-
Wang Y, Hallden G, Hill R, Anand A, Liu TC, Francis J, Brooks G, Lemoine N, Kirn D. 2003. E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models. Nat. Biotechnol. 21:1328-1335. http://dx.doi.org/10.1038/nbt887.
-
(2003)
Nat. Biotechnol.
, vol.21
, pp. 1328-1335
-
-
Wang, Y.1
Hallden, G.2
Hill, R.3
Anand, A.4
Liu, T.C.5
Francis, J.6
Brooks, G.7
Lemoine, N.8
Kirn, D.9
-
15
-
-
0041589480
-
E1A, E1B doublerestricted adenovirus for oncolytic gene therapy of gallbladder cancer
-
Fukuda K, Abei M, Ugai H, Seo E, Wakayama M, Murata T, Todoroki T, Tanaka N, Hamada H, Yokoyama KK. 2003. E1A, E1B doublerestricted adenovirus for oncolytic gene therapy of gallbladder cancer. Cancer Res. 63:4434-4440. http://cancerres.aacrjournals.org/content/63 /15/4434.long.
-
(2003)
Cancer Res.
, vol.63
, pp. 4434-4440
-
-
Fukuda, K.1
Abei, M.2
Ugai, H.3
Seo, E.4
Wakayama, M.5
Murata, T.6
Todoroki, T.7
Tanaka, N.8
Hamada, H.9
Yokoyama, K.K.10
-
16
-
-
77953537092
-
Directing systemic oncolytic viral delivery to tumors via carrier cells
-
Nakashima H, Kaur B, Chiocca EA. 2010. Directing systemic oncolytic viral delivery to tumors via carrier cells. Cytokine Growth Factor Rev. 21:119-126. http://dx.doi.org/10.1016/j.cytogfr.2010.02.004.
-
(2010)
Cytokine Growth Factor Rev.
, vol.21
, pp. 119-126
-
-
Nakashima, H.1
Kaur, B.2
Chiocca, E.A.3
-
17
-
-
27944445010
-
Oncolytic adenovirusesselective retargeting to tumor cells
-
Mathis JM, Stoff-Khalili MA, Curiel DT. 2005. Oncolytic adenovirusesselective retargeting to tumor cells. Oncogene 24:7775-7791. http://dx.doi .org/10.1038/sj.onc.1209044.
-
(2005)
Oncogene
, vol.24
, pp. 7775-7791
-
-
Mathis, J.M.1
Stoff-Khalili, M.A.2
Curiel, D.T.3
-
18
-
-
76949084531
-
Oncolytic (replication-competent) adenoviruses as anticancer agents
-
Toth K, Dhar D, Wold WS. 2010. Oncolytic (replication-competent) adenoviruses as anticancer agents. Expert Opin. Biol. Ther. 10:353-368. http://dx.doi.org/10.1517/14712590903559822.
-
(2010)
Expert Opin. Biol. Ther.
, vol.10
, pp. 353-368
-
-
Toth, K.1
Dhar, D.2
Wold, W.S.3
-
19
-
-
0032535036
-
Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations
-
Richardson C, Moynahan ME, Jasin M. 1998. Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations. Genes Dev. 12:3831-3842. http://dx.doi.org/10.1101/gad .12.24.3831.
-
(1998)
Genes Dev.
, vol.12
, pp. 3831-3842
-
-
Richardson, C.1
Moynahan, M.E.2
Jasin, M.3
-
20
-
-
0034991897
-
Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome
-
Saeki Y, Fraefel C, Ichikawa T, Breakefield XO, Chiocca EA. 2001. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol. Ther. 3:591-601. http://dx.doi.org/10.1006 /mthe.2001.0294.
-
(2001)
Mol. Ther.
, vol.3
, pp. 591-601
-
-
Saeki, Y.1
Fraefel, C.2
Ichikawa, T.3
Breakefield, X.O.4
Chiocca, E.A.5
-
21
-
-
0025847620
-
Recombinase-mediated gene activation and site-specific integration in mammalian cells
-
O'Gorman S, Fox DT, Wahl GM. 1991. Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251: 1351-1355. http://dx.doi.org/10.1126/science.1900642.
-
(1991)
Science
, vol.251
, pp. 1351-1355
-
-
O'Gorman, S.1
Fox, D.T.2
Wahl, G.M.3
-
22
-
-
79960379942
-
Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development
-
Aguilar LK, Guzik BW, Aguilar-Cordova E. 2011. Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development. J. Cell. Biochem. 112:1969-1977. http://dx.doi.org/10.1002/jcb.23126.
-
(2011)
J. Cell. Biochem.
, vol.112
, pp. 1969-1977
-
-
Aguilar, L.K.1
Guzik, B.W.2
Aguilar-Cordova, E.3
-
23
-
-
80053061789
-
Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma
-
Chiocca EA, Aguilar LK, Bell SD, Kaur B, Hardcastle J, Cavaliere R, McGregor J, Lo S, Ray-Chaudhuri A, Chakravarti A, Grecula J, Newton H, Harris KS, Grossman RG, Trask TW, Baskin DS, Monterroso C, Manzanera AG, Aguilar-Cordova E, New PZ. 2011. Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma. J. Clin. Oncol. 29: 3611-3619. http://dx.doi.org/10.1200/JCO.2011.35.5222.
-
(2011)
J. Clin. Oncol.
, vol.29
, pp. 3611-3619
-
-
Chiocca, E.A.1
Aguilar, L.K.2
Bell, S.D.3
Kaur, B.4
Hardcastle, J.5
Cavaliere, R.6
McGregor, J.7
Lo, S.8
Ray-Chaudhuri, A.9
Chakravarti, A.10
Grecula, J.11
Newton, H.12
Harris, K.S.13
Grossman, R.G.14
Trask, T.W.15
Baskin, D.S.16
Monterroso, C.17
Manzanera, A.G.18
Aguilar-Cordova, E.19
New, P.Z.20
more..
-
24
-
-
55549100223
-
Engineering microRNA responsiveness to decrease virus pathogenicity
-
Kelly EJ, Hadac EM, Greiner S, Russell SJ. 2008. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 14:1278-1283. http://dx.doi.org/10.1038/nm.1776.
-
(2008)
Nat. Med.
, vol.14
, pp. 1278-1283
-
-
Kelly, E.J.1
Hadac, E.M.2
Greiner, S.3
Russell, S.J.4
-
25
-
-
55549108699
-
Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific microRNA
-
Ylosmaki E, Hakkarainen T, Hemminki A, Visakorpi T, Andino R, Saksela K. 2008. Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific microRNA. J. Virol. 82:11009 -11015. http://dx.doi.org/10.1128/JVI .01608-08.
-
(2008)
J. Virol.
, vol.82
-
-
Ylosmaki, E.1
Hakkarainen, T.2
Hemminki, A.3
Visakorpi, T.4
Andino, R.5
Saksela, K.6
-
26
-
-
79955513981
-
Enhanced safety profiles of the telomerase-specific replication-competent adenovirus by incorporation of normal cell-specific microRNA-targeted sequences
-
Sugio K, Sakurai F, Katayama K, Tashiro K, Matsui H, Kawabata K, Kawase A, Iwaki M, Hayakawa T, Fujiwara T, Mizuguchi H. 2011. Enhanced safety profiles of the telomerase-specific replication-competent adenovirus by incorporation of normal cell-specific microRNA-targeted sequences. Clin. Cancer Res. 17:2807-2818. http://dx.doi.org/10.1158 /1078-0432.CCR-10-2008.
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 2807-2818
-
-
Sugio, K.1
Sakurai, F.2
Katayama, K.3
Tashiro, K.4
Matsui, H.5
Kawabata, K.6
Kawase, A.7
Iwaki, M.8
Hayakawa, T.9
Fujiwara, T.10
Mizuguchi, H.11
-
27
-
-
0035008659
-
Evaluation of a new dual-specificity promoter for selective induction of apoptosis in breast cancer cells
-
Hernandez-Alcoceba R, Pihalja M, Nunez G, Clarke MF. 2001. Evaluation of a new dual-specificity promoter for selective induction of apoptosis in breast cancer cells. Cancer Gene Ther. 8:298-307. http://dx.doi .org/10.1038/sj.cgt.7700304.
-
(2001)
Cancer Gene Ther.
, vol.8
, pp. 298-307
-
-
Hernandez-Alcoceba, R.1
Pihalja, M.2
Nunez, G.3
Clarke, M.F.4
-
28
-
-
0031841246
-
Tightly controlled two-stage expression vectors employing the Flp/FRT-mediated inversion of cloned genes
-
Sektas M, Szybalski W. 1998. Tightly controlled two-stage expression vectors employing the Flp/FRT-mediated inversion of cloned genes. Mol. Biotechnol. 9:17-24. http://dx.doi.org/10.1007/BF02752694.
-
(1998)
Mol. Biotechnol.
, vol.9
, pp. 17-24
-
-
Sektas, M.1
Szybalski, W.2
-
29
-
-
33845738812
-
A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication
-
Fechner H, Wang X, Pico AH, Wildner J, Suckau L, Pinkert S, Sipo I, Weger S, Poller W. 2007. A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication. J. Biotechnol. 127:560-574. http://dx.doi.org/10 .1016/j.jbiotec.2006.09.011.
-
(2007)
J. Biotechnol.
, vol.127
, pp. 560-574
-
-
Fechner, H.1
Wang, X.2
Pico, A.H.3
Wildner, J.4
Suckau, L.5
Pinkert, S.6
Sipo, I.7
Weger, S.8
Poller, W.9
-
30
-
-
0030994645
-
FLP recombinase/ estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists
-
Nichols M, Rientjes JM, Logie C, Stewart AF. 1997. FLP recombinase/ estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists. Mol. Endocrinol. 11:950-961. http://dx.doi.org/10.1210/me.11.7.950.
-
(1997)
Mol. Endocrinol.
, vol.11
, pp. 950-961
-
-
Nichols, M.1
Rientjes, J.M.2
Logie, C.3
Stewart, A.F.4
-
31
-
-
33846470670
-
Controlled expression of transgenes introduced by in vivo electroporation
-
Matsuda T, Cepko CL. 2007. Controlled expression of transgenes introduced by in vivo electroporation. Proc. Natl. Acad. Sci. U. S. A. 104:1027-1032. http://dx.doi.org/10.1073/pnas.0610155104.
-
(2007)
Proc. Natl. Acad. Sci. U. S. A.
, vol.104
, pp. 1027-1032
-
-
Matsuda, T.1
Cepko, C.L.2
-
32
-
-
0029054932
-
Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector
-
Mitani K, Graham FL, Caskey CT, Kochanek S. 1995. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc. Natl. Acad. Sci. U. S. A. 92:3854-3858. http://dx.doi.org/10 .1073/pnas.92.9.3854.
-
(1995)
Proc. Natl. Acad. Sci. U. S. A.
, vol.92
, pp. 3854-3858
-
-
Mitani, K.1
Graham, F.L.2
Caskey, C.T.3
Kochanek, S.4
-
33
-
-
0029943155
-
A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase
-
Kochanek S, Clemens PR, Mitani K, Chen HH, Chan S, Caskey CT. 1996. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad. Sci. U. S. A. 93:5731-5736. http: //dx.doi.org/10.1073/pnas.93.12.5731.
-
(1996)
Proc. Natl. Acad. Sci. U. S. A.
, vol.93
, pp. 5731-5736
-
-
Kochanek, S.1
Clemens, P.R.2
Mitani, K.3
Chen, H.H.4
Chan, S.5
Caskey, C.T.6
-
34
-
-
0033818222
-
Yeast recombinase FLP functions effectively in human cells for construction of adenovirus vectors
-
528
-
Ng P, Cummings DT, Evelegh CM, Graham FL. 2000. Yeast recombinase FLP functions effectively in human cells for construction of adenovirus vectors. Biotechniques 29:524-526, 528. http://www.biotechniques .com/multimedia/archive/00011/00293st04_11792a.pdf.
-
(2000)
Biotechniques
, vol.29
, pp. 524-526
-
-
Ng, P.1
Cummings, D.T.2
Evelegh, C.M.3
Graham, F.L.4
-
35
-
-
0035005627
-
Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helpervirus contamination
-
Umana P, Gerdes CA, Stone D, Davis JR, Ward D, Castro MG, Lowenstein PR. 2001. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helpervirus contamination. Nat. Biotechnol. 19:582-585. http://dx.doi.org/10 .1038/89349.
-
(2001)
Nat. Biotechnol.
, vol.19
, pp. 582-585
-
-
Umana, P.1
Gerdes, C.A.2
Stone, D.3
Davis, J.R.4
Ward, D.5
Castro, M.G.6
Lowenstein, P.R.7
-
36
-
-
79952143411
-
Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives
-
Vetrini F, Ng P. 2010. Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives. Viruses 2:1886-1917. http://dx.doi.org/10.3390/v2091886.
-
(2010)
Viruses
, vol.2
, pp. 1886-1917
-
-
Vetrini, F.1
Ng, P.2
-
37
-
-
79958240552
-
Intrathecal injection of helper-dependent adenoviral vectors results in long-term transgene expression in neuroependymal cells and neurons
-
Dindot S, Piccolo P, Grove N, Palmer D, Brunetti-Pierri N. 2011. Intrathecal injection of helper-dependent adenoviral vectors results in long-term transgene expression in neuroependymal cells and neurons. Hum. Gene Ther. 22:745-751. http://dx.doi.org/10.1089/hum.2010.147.
-
(2011)
Hum. Gene Ther.
, vol.22
, pp. 745-751
-
-
Dindot, S.1
Piccolo, P.2
Grove, N.3
Palmer, D.4
Brunetti-Pierri, N.5
-
38
-
-
0024041732
-
Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1
-
Sauer B, Henderson N. 1988. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. U. S. A. 85:5166 -5170. http://dx.doi.org/10.1073/pnas .85.14.5166.
-
(1988)
Proc. Natl. Acad. Sci. U. S. A.
, vol.85
-
-
Sauer, B.1
Henderson, N.2
-
39
-
-
0031874849
-
Improved properties of FLP recombinase evolved by cycling mutagenesis
-
Buchholz F, Angrand PO, Stewart AF. 1998. Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat. Biotechnol. 16:657-662. http://dx.doi.org/10.1038/nbt0798-657.
-
(1998)
Nat. Biotechnol.
, vol.16
, pp. 657-662
-
-
Buchholz, F.1
Angrand, P.O.2
Stewart, A.F.3
|